Business
Biotech Firm Lists in Hong Kong
A U.S. biotech firm is listing on the Hong Kong stock exchange, attracted by its growing investor base and proximity to Chinese pharmaceutical partners. This trend reflects broader interest from global firms in accessing the region's market.
Coverage timeline — 1 article
CNBC
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
2026-07-22 00:15 UTC